Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates.
Identifieur interne : 000142 ( Main/Corpus ); précédent : 000141; suivant : 000143Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates.
Auteurs : Donglu Zhang ; Aimee Fourie-O'Donohue ; Peter S. Dragovich ; Thomas H. Pillow ; Jack D. Sadowsky ; Katherine R. Kozak ; Robert T. Cass ; Liling Liu ; Yuzhong Deng ; Yichin Liu ; Cornelis E C A. Hop ; S Cyrus KhojastehSource :
- Drug metabolism and disposition: the biological fate of chemicals [ 1521-009X ] ; 2019.
English descriptors
- KwdEn :
- Animals (MeSH), Benzodiazepines (chemistry), Benzodiazepines (metabolism), Disulfides (chemistry), Disulfides (metabolism), Female (MeSH), Glutaredoxins (metabolism), Humans (MeSH), Immunoconjugates (chemistry), Immunoconjugates (pharmacokinetics), Male (MeSH), Pyrroles (chemistry), Pyrroles (metabolism), Rats (MeSH), Recombinant Proteins (metabolism), Thioredoxin-Disulfide Reductase (metabolism), Thioredoxins (metabolism).
- MESH :
- chemical , chemistry : Benzodiazepines, Disulfides, Immunoconjugates, Pyrroles.
- chemical , metabolism : Benzodiazepines, Disulfides, Glutaredoxins, Pyrroles, Recombinant Proteins, Thioredoxin-Disulfide Reductase, Thioredoxins.
- chemical , pharmacokinetics : Immunoconjugates.
- Animals, Female, Humans, Male, Rats.
Abstract
In cells, catalytic disulfide cleavage is an essential mechanism in protein folding and synthesis. However, detailed enzymatic catalytic mechanism relating cleavage of disulfide bonds in xenobiotics is not well understood. This study reports an enzymatic mechanism of cleavage of disulfide bonds in xenobiotic small molecules and antibody conjugate (ADC) linkers. The chemically stable disulfide bonds in substituted disulfide-containing pyrrolobenzodiazepine (PBD, pyrrolo[2,1-c][1,4]benzodiazepine) monomer prodrugs in presence of glutathione or cysteine were found to be unstable in incubations in whole blood of humans and rats. It was shown the enzymes involved were thioredoxin (TRX) and glutaredoxin (GRX). For a diverse set of drug-linker conjugates, we determined that TRX in the presence of TRX-reductase and NADPH generated the cleaved products that are consistent with catalytic disulfide cleavage and linker immolation. GRX was less rigorously studied; in the set of compounds studied, its role in the catalytic cleavage was also confirmed. Collectively, these in vitro experiments demonstrate that TRX as well as GRX can catalyze the cleavage of disulfide bonds in both small molecules and linkers of ADCs.
DOI: 10.1124/dmd.118.086132
PubMed: 31085544
Links to Exploration step
pubmed:31085544Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates.</title><author><name sortKey="Zhang, Donglu" sort="Zhang, Donglu" uniqKey="Zhang D" first="Donglu" last="Zhang">Donglu Zhang</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California zhang.donglu@gene.com.</nlm:affiliation></affiliation></author><author><name sortKey="Fourie O Donohue, Aimee" sort="Fourie O Donohue, Aimee" uniqKey="Fourie O Donohue A" first="Aimee" last="Fourie-O'Donohue">Aimee Fourie-O'Donohue</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Dragovich, Peter S" sort="Dragovich, Peter S" uniqKey="Dragovich P" first="Peter S" last="Dragovich">Peter S. Dragovich</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Pillow, Thomas H" sort="Pillow, Thomas H" uniqKey="Pillow T" first="Thomas H" last="Pillow">Thomas H. Pillow</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Sadowsky, Jack D" sort="Sadowsky, Jack D" uniqKey="Sadowsky J" first="Jack D" last="Sadowsky">Jack D. Sadowsky</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Kozak, Katherine R" sort="Kozak, Katherine R" uniqKey="Kozak K" first="Katherine R" last="Kozak">Katherine R. Kozak</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Cass, Robert T" sort="Cass, Robert T" uniqKey="Cass R" first="Robert T" last="Cass">Robert T. Cass</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Liu, Liling" sort="Liu, Liling" uniqKey="Liu L" first="Liling" last="Liu">Liling Liu</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Deng, Yuzhong" sort="Deng, Yuzhong" uniqKey="Deng Y" first="Yuzhong" last="Deng">Yuzhong Deng</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Liu, Yichin" sort="Liu, Yichin" uniqKey="Liu Y" first="Yichin" last="Liu">Yichin Liu</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Hop, Cornelis E C A" sort="Hop, Cornelis E C A" uniqKey="Hop C" first="Cornelis E C A" last="Hop">Cornelis E C A. Hop</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Khojasteh, S Cyrus" sort="Khojasteh, S Cyrus" uniqKey="Khojasteh S" first="S Cyrus" last="Khojasteh">S Cyrus Khojasteh</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California khojasteh.cyrus@gene.com.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31085544</idno><idno type="pmid">31085544</idno><idno type="doi">10.1124/dmd.118.086132</idno><idno type="wicri:Area/Main/Corpus">000142</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000142</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates.</title><author><name sortKey="Zhang, Donglu" sort="Zhang, Donglu" uniqKey="Zhang D" first="Donglu" last="Zhang">Donglu Zhang</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California zhang.donglu@gene.com.</nlm:affiliation></affiliation></author><author><name sortKey="Fourie O Donohue, Aimee" sort="Fourie O Donohue, Aimee" uniqKey="Fourie O Donohue A" first="Aimee" last="Fourie-O'Donohue">Aimee Fourie-O'Donohue</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Dragovich, Peter S" sort="Dragovich, Peter S" uniqKey="Dragovich P" first="Peter S" last="Dragovich">Peter S. Dragovich</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Pillow, Thomas H" sort="Pillow, Thomas H" uniqKey="Pillow T" first="Thomas H" last="Pillow">Thomas H. Pillow</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Sadowsky, Jack D" sort="Sadowsky, Jack D" uniqKey="Sadowsky J" first="Jack D" last="Sadowsky">Jack D. Sadowsky</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Kozak, Katherine R" sort="Kozak, Katherine R" uniqKey="Kozak K" first="Katherine R" last="Kozak">Katherine R. Kozak</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Cass, Robert T" sort="Cass, Robert T" uniqKey="Cass R" first="Robert T" last="Cass">Robert T. Cass</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Liu, Liling" sort="Liu, Liling" uniqKey="Liu L" first="Liling" last="Liu">Liling Liu</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Deng, Yuzhong" sort="Deng, Yuzhong" uniqKey="Deng Y" first="Yuzhong" last="Deng">Yuzhong Deng</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Liu, Yichin" sort="Liu, Yichin" uniqKey="Liu Y" first="Yichin" last="Liu">Yichin Liu</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Hop, Cornelis E C A" sort="Hop, Cornelis E C A" uniqKey="Hop C" first="Cornelis E C A" last="Hop">Cornelis E C A. Hop</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</nlm:affiliation></affiliation></author><author><name sortKey="Khojasteh, S Cyrus" sort="Khojasteh, S Cyrus" uniqKey="Khojasteh S" first="S Cyrus" last="Khojasteh">S Cyrus Khojasteh</name><affiliation><nlm:affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California khojasteh.cyrus@gene.com.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Drug metabolism and disposition: the biological fate of chemicals</title><idno type="eISSN">1521-009X</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term><term>Benzodiazepines (chemistry)</term><term>Benzodiazepines (metabolism)</term><term>Disulfides (chemistry)</term><term>Disulfides (metabolism)</term><term>Female (MeSH)</term><term>Glutaredoxins (metabolism)</term><term>Humans (MeSH)</term><term>Immunoconjugates (chemistry)</term><term>Immunoconjugates (pharmacokinetics)</term><term>Male (MeSH)</term><term>Pyrroles (chemistry)</term><term>Pyrroles (metabolism)</term><term>Rats (MeSH)</term><term>Recombinant Proteins (metabolism)</term><term>Thioredoxin-Disulfide Reductase (metabolism)</term><term>Thioredoxins (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Benzodiazepines</term><term>Disulfides</term><term>Immunoconjugates</term><term>Pyrroles</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Benzodiazepines</term><term>Disulfides</term><term>Glutaredoxins</term><term>Pyrroles</term><term>Recombinant Proteins</term><term>Thioredoxin-Disulfide Reductase</term><term>Thioredoxins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Immunoconjugates</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Female</term><term>Humans</term><term>Male</term><term>Rats</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In cells, catalytic disulfide cleavage is an essential mechanism in protein folding and synthesis. However, detailed enzymatic catalytic mechanism relating cleavage of disulfide bonds in xenobiotics is not well understood. This study reports an enzymatic mechanism of cleavage of disulfide bonds in xenobiotic small molecules and antibody conjugate (ADC) linkers. The chemically stable disulfide bonds in substituted disulfide-containing pyrrolobenzodiazepine (PBD, pyrrolo[2,1-c][1,4]benzodiazepine) monomer prodrugs in presence of glutathione or cysteine were found to be unstable in incubations in whole blood of humans and rats. It was shown the enzymes involved were thioredoxin (TRX) and glutaredoxin (GRX). For a diverse set of drug-linker conjugates, we determined that TRX in the presence of TRX-reductase and NADPH generated the cleaved products that are consistent with catalytic disulfide cleavage and linker immolation. GRX was less rigorously studied; in the set of compounds studied, its role in the catalytic cleavage was also confirmed. Collectively, these in vitro experiments demonstrate that TRX as well as GRX can catalyze the cleavage of disulfide bonds in both small molecules and linkers of ADCs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31085544</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-009X</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>10</Month></PubDate></JournalIssue><Title>Drug metabolism and disposition: the biological fate of chemicals</Title><ISOAbbreviation>Drug Metab Dispos</ISOAbbreviation></Journal><ArticleTitle>Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates.</ArticleTitle><Pagination><MedlinePgn>1156-1163</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1124/dmd.118.086132</ELocationID><Abstract><AbstractText>In cells, catalytic disulfide cleavage is an essential mechanism in protein folding and synthesis. However, detailed enzymatic catalytic mechanism relating cleavage of disulfide bonds in xenobiotics is not well understood. This study reports an enzymatic mechanism of cleavage of disulfide bonds in xenobiotic small molecules and antibody conjugate (ADC) linkers. The chemically stable disulfide bonds in substituted disulfide-containing pyrrolobenzodiazepine (PBD, pyrrolo[2,1-c][1,4]benzodiazepine) monomer prodrugs in presence of glutathione or cysteine were found to be unstable in incubations in whole blood of humans and rats. It was shown the enzymes involved were thioredoxin (TRX) and glutaredoxin (GRX). For a diverse set of drug-linker conjugates, we determined that TRX in the presence of TRX-reductase and NADPH generated the cleaved products that are consistent with catalytic disulfide cleavage and linker immolation. GRX was less rigorously studied; in the set of compounds studied, its role in the catalytic cleavage was also confirmed. Collectively, these in vitro experiments demonstrate that TRX as well as GRX can catalyze the cleavage of disulfide bonds in both small molecules and linkers of ADCs.</AbstractText><CopyrightInformation>Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Donglu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California zhang.donglu@gene.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fourie-O'Donohue</LastName><ForeName>Aimee</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dragovich</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillow</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadowsky</LastName><ForeName>Jack D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozak</LastName><ForeName>Katherine R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cass</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yuzhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yichin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hop</LastName><ForeName>Cornelis E C A</ForeName><Initials>CECA</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khojasteh</LastName><ForeName>S Cyrus</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Drug Metabolism & Pharmacokinetics (D.Z., R.T.C., L.L., Y.D., C.E.C.A.H., S.C.K.), Biochemical and Cellular Pharmacology (A.F.-O., K.R.K., Y.L.), Discovery Chemistry (P.S.D., T.H.P.), and Protein Chemistry (J.D.S.), Genentech, Inc., South San Francisco, California khojasteh.cyrus@gene.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Drug Metab Dispos</MedlineTA><NlmUniqueID>9421550</NlmUniqueID><ISSNLinking>0090-9556</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004220">Disulfides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C516005">GLRX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018796">Immunoconjugates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491203">TXN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495697">Txn1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C438462">pyrrolo(2,1-c)(1,4)benzodiazepine</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>52500-60-4</RegistryNumber><NameOfSubstance UI="D013879">Thioredoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.8.1.9</RegistryNumber><NameOfSubstance UI="D013880">Thioredoxin-Disulfide Reductase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004220" MajorTopicYN="N">Disulfides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018796" MajorTopicYN="N">Immunoconjugates</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013880" MajorTopicYN="N">Thioredoxin-Disulfide Reductase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013879" MajorTopicYN="N">Thioredoxins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>05</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31085544</ArticleId><ArticleId IdType="pii">dmd.118.086132</ArticleId><ArticleId IdType="doi">10.1124/dmd.118.086132</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000142 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000142 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= GlutaredoxinV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:31085544
|texte= Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:31085544" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GlutaredoxinV1
| This area was generated with Dilib version V0.6.37. |  |